SCHEMBL8851180

SCHEMBL8851180

CCCOC(=O)CCNC

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.47
ALDH1A1 P00352 3/20 0.46
GLA P06280 1/20 0.46
TOP2A P11388 2/20 0.45
EPHX2 P34913 1/20 0.40
ADRA2A P08913 1/20 0.40
ADRA1A P35348 1/20 0.40
DNM1 Q05193 1/20 0.39
MAPT P10636 3/20 0.39
BLM P54132 1/20 0.39
LMNA P02545 2/20 0.38
HTR2C P28335 1/20 0.38
NAAA Q02083 1/20 0.38
TDP1 Q9NUW8 1/20 0.36
ACHE P22303 1/20 0.36
MAPK1 P28482 1/20 0.36
HCAR2 Q8TDS4 1/20 0.36
USP2 O75604 1/20 0.36
LTA4H P09960 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20924890 0.88 DGKA (0.53) DGKAALDH1A1GLATOP2AEPHX2
SCHEMBL591366 0.86 NAAA (0.57) DGKAEPHX2DNM1HTR2CNAAA
SCHEMBL16858346 0.83 DGKA (0.47) DGKAALDH1A1GLATOP2AEPHX2
SCHEMBL13245883 0.83 ACHE (0.41) DGKAALDH1A1GLATOP2AEPHX2
SCHEMBL498980 0.82
SCHEMBL20589 0.81 DGKA (0.58) DGKAALDH1A1GLAADRA2AADRA1A
SCHEMBL889155 0.81 ALDH1A1 (0.45) DGKAALDH1A1GLATOP2AEPHX2
SCHEMBL25922718 0.81 ALDH1A1 (0.43) DGKAALDH1A1GLAADRA2AADRA1A
SCHEMBL20251128 0.81 DGKA (0.41) DGKAALDH1A1GLAADRA2AADRA1A
SCHEMBL8851411 0.81 ALDH1A1 (0.45) DGKAALDH1A1GLATOP2AEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3432934-B1 PRODRUGS OF CYTOTOXIC AGENTS WITH ENZYMATICALLY CLEAVABLE GROUPS Bayer Pharma AG (DE) 2022-02-23 EP disclosed
US-5618814-A Trisubstituted pyrimido [5,4-d] pyrimidines for modulating multi-drug resistance and pharmaceutical compositions containing these compounds DR. KARL THOMAE GMBH (DE) 1997-04-08 US disclosed